The development p38 MAP kinase inhibitors

被引：0

作者：

Hynes, John ^{[1
]}

Wu, H. ^{[1
]}

Dyckman, A. J. ^{[1
]}

Lin, S. ^{[1
]}

Wrobleski, S. T. ^{[1
]}

Gillooly, K. M. ^{[1
]}

McIntyre, K. W. ^{[1
]}

Pitt, S. ^{[1
]}

Shen, D. R. ^{[1
]}

Shuster, D. J. ^{[1
]}

Xia, X. ^{[1
]}

Zhang, R. ^{[1
]}

机构：

[1] Bristol Myers Squibb, Dept Discovery Chem, Princeton, NJ USA

来源：

INFLAMMATION RESEARCH | 2007年 / 56卷

关键词：

D O I：

暂无

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：S474 / S474

页数：1

共 50 条

[1] Inhibitors of p38α MAP kinase
Chakravarty, S
[J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 37, 2002, 37 : 177 - 186
[2] Potent inhibitors of the map kinase p38
Henry, JR
Rupert, KC
Dodd, JH
Turchi, IJ
Wadsworth, SA
Cavender, DE
Schafer, PH
Siekierka, JJ
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (23) : 3335 - 3340
[3] Inhibitors of unactivated p38 MAP kinase
Bullington, James
Argentieri, Dennis
Averill, Kristin
Carter, Demetrius
Cavender, Druie
Fahmy, Bohumila
Fan, Xiaodong
Hall, Daniel
Heintzelman, Geoffrey
Jackson, Paul
Leung, Wai-Ping
Li, Xun
Ling, Ping
Olini, Gilbert
Razler, Thomas
Reuman, Michael
Rupert, Kenneth
Russell, Ronald
Siekierka, John
Wadsworth, Scott
Wolff, Russell
Xiang, Bangping
Zhang, Yue-Mei
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (23) : 6102 - 6106
[4] Process Research and Development for Heterocyclic p38 MAP Kinase Inhibitors
Thiel, Oliver R.
Achmatowicz, Michal
Milburn, Robert M.
[J]. SYNLETT, 2012, (11) : 1564 - 1574
[5] Novel inhibitors of p38 MAP kinase.
Shetty, R
Moffett, KK
Nguyen, D
Kelly, MJ
Michelotti, EL
Dorsey, BD
Springman, E
Bukhtiyarova, M
Northrop, K
Chai, XM
Saporito, MS
Ochman, AR
Karpusas, M
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U947 - U947
[6] Imidazopyrimidines, potent inhibitors of p38 MAP kinase
Rupert, KC
Henry, JR
Dodd, JH
Wadsworth, SA
Cavender, DE
Olini, GC
Fahmy, B
Siekierka, JJ
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 347 - 350
[7] Benzothiazole based inhibitors of p38α MAP kinase
Liu, Chunjian
Lin, James
Pitt, Sidney
Zhang, Rosemary F.
Sack, John S.
Kiefer, Susan E.
Kish, Kevin
Doweyko, Arthur M.
Zhang, Hongjian
Marathe, Punit H.
Trzaskos, James
Mckinnon, Murray
Dodd, John H.
Barrish, Joel C.
Schieven, Gary L.
Leftheris, Katerina
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (06) : 1874 - 1879
[8] P38 MAP kinase inhibitors for the treatment of arthritis
Barlocco, D
Langston, S
[J]. DRUG DISCOVERY TODAY, 2001, 6 (15) : 808 - 809
[9] P38 α map kinase inhibitors:: From discovery to the clinic
Dugar, S
Mavunkel, B
Chakravarty, S
Perumattam, J
Luedtke, G
Lu, Q
Chen, Z
Xu, YJ
Protter, A
Schreiner, G
Almirez, R
Scott, B
Laney, M
Henson, M
Lewicki, J
Moore, A
Lee, S
Brahn, E
Liu, D
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U162 - U162
[10] p38 MAP kinase inhibitors: Progress, pitfalls and possibilities
Adams, JL
Gallagher, TF
Boehm, JC
Kassis, S
Gorycki, PD
Gum, RJ
Webb, EF
Sorenson, ME
Smietana, JM
Garigipati, RS
Hall, RF
Ayrton, A
Badger, A
Griswold, DE
Young, PR
Lee, JC
[J]. MEDICINAL CHEMISTRY INTO THE MILLENNIUM, 2001, (264): : 163 - 173

← 1 2 3 4 5 →